28539885|t|Intranasal Insulin Prevents Anesthesia - Induced Cognitive Impairment and Chronic Neurobehavioral Changes
28539885|a|General anesthesia increases the risk for cognitive impairment post operation, especially in the elderly and vulnerable individuals. Recent animal studies on the impact of anesthesia on postoperative cognitive impairment have provided some valuable insights, but much remains to be understood. Here, by using mice of various ages and conditions, we found that anesthesia with propofol and sevoflurane caused significant deficits in spatial learning and memory, as tested using Morris Water Maze (MWM) 2-6 days after anesthesia exposure, in aged (17-18 months old) wild-type (WT) mice and in adult (7-8 months old) 3xTg-AD mice (a triple transgenic mouse model of Alzheimer's disease (AD)), but not in adult WT mice. Anesthesia resulted in long-term neurobehavioral changes in the fear conditioning task carried out 65 days after exposure to anesthesia in 3xTg-AD mice. Importantly, daily intranasal administration of insulin (1.75 U/ mouse / day) for only 3 days prior to anesthesia completely prevented the anesthesia - induced deficits in spatial learning and memory and the long-term neurobehavioral changes tested 65 days after exposure to anesthesia in 3xTg-AD mice. These results indicate that aging and AD -like brain pathology increase the vulnerability to cognitive impairment after anesthesia and that intranasal treatment with insulin can prevent anesthesia - induced cognitive impairment.
28539885	0	10	Intranasal	T058	UMLS:C0001560
28539885	11	18	Insulin	T103	UMLS:C0021641
28539885	28	38	Anesthesia	T058	UMLS:C0002903
28539885	49	69	Cognitive Impairment	T038	UMLS:C0338656
28539885	106	124	General anesthesia	T058	UMLS:C0002915
28539885	148	168	cognitive impairment	T038	UMLS:C0338656
28539885	203	210	elderly	T098	UMLS:C0001792
28539885	215	237	vulnerable individuals	T098	UMLS:C0949366
28539885	246	260	animal studies	T204	UMLS:C0683949
28539885	278	288	anesthesia	T058	UMLS:C0002903
28539885	306	326	cognitive impairment	T038	UMLS:C0338656
28539885	415	419	mice	T204	UMLS:C0025929
28539885	466	476	anesthesia	T058	UMLS:C0002903
28539885	482	490	propofol	T103	UMLS:C0033487
28539885	495	506	sevoflurane	T103	UMLS:C0074414
28539885	583	600	Morris Water Maze	T058	UMLS:C0022885
28539885	602	605	MWM	T058	UMLS:C0022885
28539885	670	689	wild-type (WT) mice	T204	UMLS:C1520150
28539885	720	732	3xTg-AD mice	T204	UMLS:C0025936
28539885	736	759	triple transgenic mouse	T204	UMLS:C0025936
28539885	760	765	model	T038	UMLS:C1519606
28539885	769	788	Alzheimer's disease	T038	UMLS:C0002395
28539885	790	792	AD	T038	UMLS:C0002395
28539885	813	820	WT mice	T204	UMLS:C1520150
28539885	822	832	Anesthesia	T058	UMLS:C0002903
28539885	961	973	3xTg-AD mice	T204	UMLS:C0025936
28539885	994	1019	intranasal administration	T058	UMLS:C0001560
28539885	1023	1030	insulin	T103	UMLS:C0021641
28539885	1040	1045	mouse	T204	UMLS:C0025929
28539885	1078	1088	anesthesia	T058	UMLS:C0002903
28539885	1114	1124	anesthesia	T058	UMLS:C0002903
28539885	1264	1276	3xTg-AD mice	T204	UMLS:C0025936
28539885	1306	1311	aging	T038	UMLS:C0001811
28539885	1316	1318	AD	T038	UMLS:C0002395
28539885	1325	1340	brain pathology	T038	UMLS:C0006119
28539885	1371	1391	cognitive impairment	T038	UMLS:C0338656
28539885	1398	1408	anesthesia	T058	UMLS:C0002903
28539885	1418	1438	intranasal treatment	T058	UMLS:C0001560
28539885	1444	1451	insulin	T103	UMLS:C0021641
28539885	1464	1474	anesthesia	T058	UMLS:C0002903
28539885	1485	1505	cognitive impairment	T038	UMLS:C0338656